These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8263773)

  • 21. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
    Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
    Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.
    Wijetunge S; Lymn JS; Hughes AD
    Br J Pharmacol; 2000 Apr; 129(7):1347-54. PubMed ID: 10742290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle.
    Sauro MD; Fitzpatrick DF
    Pept Res; 1990; 3(3):138-41. PubMed ID: 1966864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
    Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
    Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion.
    Gao YJ; Takemori K; Su LY; An WS; Lu C; Sharma AM; Lee RM
    Cardiovasc Res; 2006 Jul; 71(2):363-73. PubMed ID: 16756966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
    Touyz RM; Schiffrin EL
    Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.
    Erlinge D; Heilig M; Edvinsson L
    Br J Pharmacol; 1996 Jun; 118(4):1028-34. PubMed ID: 8799578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etomidate attenuates phenylephrine-induced contraction in isolated rat aorta.
    Shin IW; Sohn JT; Kim HJ; Kim C; Lee HK; Chang KC; Chung YK
    Can J Anaesth; 2005 Nov; 52(9):927-34. PubMed ID: 16251557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine kinase inhibition suppresses angiotensin contraction in hypertensive and normotensive small resistance arteries.
    Malloy LG; Sauro MD
    Life Sci; 1996; 58(19):PL317-24. PubMed ID: 8632696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor.
    Fujio Y; Yamada F; Takahashi K; Shibata N
    Biochem Biophys Res Commun; 1993 Aug; 195(1):79-83. PubMed ID: 7689842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells.
    Wijetunge S; Hughes AD
    Br J Pharmacol; 1995 Jun; 115(3):534-8. PubMed ID: 7582469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension.
    Silver PJ; Michalak RJ; Kocmund SM
    J Pharmacol Exp Ther; 1985 Mar; 232(3):595-601. PubMed ID: 2983064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
    Ramdas L; McMurray JS; Budde RJ
    Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).
    Chen Z; Lee FY; Bhalla KN; Wu J
    Mol Pharmacol; 2006 May; 69(5):1527-33. PubMed ID: 16436588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular calcium regulatory machinery of vasorelaxation elicited by petasin.
    Wang GJ; Lin YL; Chen CH; Wu XC; Liao JF; Ren J
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):309-15. PubMed ID: 19719750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic actions of epidermal growth factor-urogastrone and vasopressin in cultured aortic A-10 smooth muscle cells.
    Mokashi S; Severson DL; Hollenberg MD
    J Cell Physiol; 1992 Aug; 152(2):372-81. PubMed ID: 1386368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the involvement of protein kinase C in acidic pH-induced contraction in spontaneously hypertensive rat aorta.
    Rohra DK; Yamakuni T; Ito S; Saito SY; Ohizumi Y
    Pharmacology; 2004 May; 71(1):10-6. PubMed ID: 15051918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cobalt contraction of vascular smooth muscle is calcium dependent.
    Gallagher MJ; Alade PI; Dominiczak AF; Bohr DF
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):293-7. PubMed ID: 7526063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.